Logo image of PL

PLANET LABS PBC (PL) Stock Fundamental Analysis

NYSE:PL - New York Stock Exchange, Inc. - US72703X1063 - Common Stock

4.56  -0.11 (-2.36%)

Fundamental Rating

4

Taking everything into account, PL scores 4 out of 10 in our fundamental rating. PL was compared to 82 industry peers in the Professional Services industry. No worries on liquidiy or solvency for PL as it has an excellent financial health rating, but there are worries on the profitability. PL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PL had negative earnings in the past year.
PL had a negative operating cash flow in the past year.
In the past 5 years PL always reported negative net income.
In the past 5 years PL always reported negative operating cash flow.
PL Yearly Net Income VS EBIT VS OCF VS FCFPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

PL's Return On Assets of -18.73% is on the low side compared to the rest of the industry. PL is outperformed by 86.08% of its industry peers.
The Return On Equity of PL (-25.43%) is worse than 79.75% of its industry peers.
Industry RankSector Rank
ROA -18.73%
ROE -25.43%
ROIC N/A
ROA(3y)-19.41%
ROA(5y)-24.83%
ROE(3y)-25.47%
ROE(5y)-50.3%
ROIC(3y)N/A
ROIC(5y)N/A
PL Yearly ROA, ROE, ROICPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

PL has a Gross Margin of 55.99%. This is in the better half of the industry: PL outperforms 65.82% of its industry peers.
In the last couple of years the Gross Margin of PL has grown nicely.
PL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.27%
GM growth 5YN/A
PL Yearly Profit, Operating, Gross MarginsPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100

7

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PL has been increased compared to 1 year ago.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PL Yearly Shares OutstandingPL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
PL Yearly Total Debt VS Total AssetsPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.49 indicates that PL is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.49, PL is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.49
ROIC/WACCN/A
WACC9.34%
PL Yearly LT Debt VS Equity VS FCFPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.34 indicates that PL has no problem at all paying its short term obligations.
The Current ratio of PL (2.34) is better than 81.01% of its industry peers.
A Quick Ratio of 2.34 indicates that PL has no problem at all paying its short term obligations.
PL's Quick ratio of 2.34 is amongst the best of the industry. PL outperforms 81.01% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34
PL Yearly Current Assets VS Current LiabilitesPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

PL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
The Revenue has grown by 12.49% in the past year. This is quite good.
Measured over the past years, PL shows a very strong growth in Revenue. The Revenue has been growing by 24.93% on average per year.
EPS 1Y (TTM)51.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)12.49%
Revenue growth 3Y24.93%
Revenue growth 5YN/A
Sales Q2Q%10.64%

3.2 Future

PL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.77% yearly.
PL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.20% yearly.
EPS Next Y44.61%
EPS Next 2Y32.46%
EPS Next 3Y22.77%
EPS Next 5YN/A
Revenue Next Year11.36%
Revenue Next 2Y11.72%
Revenue Next 3Y14.2%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PL Yearly Revenue VS EstimatesPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
PL Yearly EPS VS EstimatesPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

PL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PL Price Earnings VS Forward Price EarningsPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PL Per share dataPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PL's earnings are expected to grow with 22.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.46%
EPS Next 3Y22.77%

0

5. Dividend

5.1 Amount

No dividends for PL!.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (1/22/2025, 11:41:00 AM)

4.56

-0.11 (-2.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)12-09 2024-12-09/amc
Earnings (Next)N/A N/A
Inst Owners51.18%
Inst Owner Change-0.02%
Ins Owners2.38%
Ins Owner Change-0.66%
Market Cap1.35B
Analysts82.22
Price Target4.76 (4.39%)
Short Float %1.83%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.01%
Min EPS beat(2)8.57%
Max EPS beat(2)51.46%
EPS beat(4)4
Avg EPS beat(4)23.88%
Min EPS beat(4)8.57%
Max EPS beat(4)51.46%
EPS beat(8)8
Avg EPS beat(8)22.56%
EPS beat(12)10
Avg EPS beat(12)10.44%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.91%
Min Revenue beat(2)-5.76%
Max Revenue beat(2)-4.05%
Revenue beat(4)0
Avg Revenue beat(4)-3.47%
Min Revenue beat(4)-5.76%
Max Revenue beat(4)-1.8%
Revenue beat(8)0
Avg Revenue beat(8)-3.2%
Revenue beat(12)2
Avg Revenue beat(12)-1.14%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.81%
PT rev (3m)17.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.47%
EPS NY rev (1m)0%
EPS NY rev (3m)22.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-2.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.6
P/FCF N/A
P/OCF N/A
P/B 2.91
P/tB 4.84
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.81
BVpS1.57
TBVpS0.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.73%
ROE -25.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.99%
FCFM N/A
ROA(3y)-19.41%
ROA(5y)-24.83%
ROE(3y)-25.47%
ROE(5y)-50.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.27%
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.76%
Cap/Sales 19.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z 2.49
F-Score5
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)50.54%
Cap/Depr(5y)46.22%
Cap/Sales(3y)12.42%
Cap/Sales(5y)17.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y44.61%
EPS Next 2Y32.46%
EPS Next 3Y22.77%
EPS Next 5YN/A
Revenue 1Y (TTM)12.49%
Revenue growth 3Y24.93%
Revenue growth 5YN/A
Sales Q2Q%10.64%
Revenue Next Year11.36%
Revenue Next 2Y11.72%
Revenue Next 3Y14.2%
Revenue Next 5YN/A
EBIT growth 1Y28.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.57%
EBIT Next 3Y35.02%
EBIT Next 5YN/A
FCF growth 1Y36.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.43%
OCF growth 3YN/A
OCF growth 5YN/A